Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Mitigating ipatasertib-induced glucose increase through dose and meal timing modifications.
Journal: Clinical and translational science
Published: August 26, 2022
Impact of Anti-HER2 Treatments Combined With Atezolizumab on the Tumor Immune Microenvironment in Early or Metastatic Breast Cancer: Results From a Phase Ib Study.
Journal: Clinical breast cancer
Published: February 19, 2021
Somatic variants of potential clinical significance in the tumors of BRCA phenocopies.
Journal: Hereditary cancer in clinical practice
Published: May 02, 2019
Misdiagnosis of Li-Fraumeni Syndrome in a Patient With Clonal Hematopoiesis and a Somatic TP53 Mutation.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: July 06, 2017
Can chimerism explain breast/ovarian cancers in BRCA non-carriers from BRCA-positive families?
Journal: PloS one
Published: May 12, 2017
Evaluation of Pulmonary Complications in Robotic-Assisted Gynecologic Surgery.
Journal: Journal of minimally invasive gynecology
Published: April 19, 2016
A Delay from Diagnosis to Treatment Is Associated with a Decreased Overall Survival for Patients with Endometrial Cancer.
Journal: Frontiers in oncology
Published: November 19, 2015
A phase II study of paclitaxel for the treatment of ovarian stromal tumors: An NRG Oncology/ Gynecologic Oncology Group Study.
Journal: Gynecologic oncology
Published: October 04, 2015
Identifying distinct nanoscopic features of native collagen fibrils towards early diagnosis of pelvic organ prolapse.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: July 22, 2015
A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.
Journal: Gynecologic oncology
Published: April 23, 2015
A phase II evaluation of selumetinib (AZD6244, ARRY-142886), a selective MEK-1/2 inhibitor in the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group study.
Journal: Gynecologic oncology
Published: February 18, 2015
A Phase II evaluation of ixabepilone (IND #59699, NSC #710428) in the treatment of recurrent or persistent leiomyosarcoma of the uterus: an NRG Oncology/Gynecologic Oncology Group Study.
Journal: Gynecologic oncology
Published: May 29, 2014
Last Updated: 09/26/2026